Patents by Inventor Fujio Matsuo

Fujio Matsuo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MEDICAMENT FOR IMPROVING PROGNOSTIC SURVIVAL IN THERAPY OF MALIGNANT TUMOR
    Publication number: 20100120693
    Abstract: A medicament for improving prognostic survival in therapy of malignant tumor is provided that may improve prognostic survival in DIC patients where the basal disease is malignant tumor, especially malignant tumor in hematopoietic organs. The medicament according to the invention comprises as a main active ingredient Activated Protein C, which is obtained from plasma or prepared by using the genetic recombination technique, and efficiently prolongs life-span of DIC patients where the basal disease is malignant tumor, especially malignant tumor in hematopoietic organs. In particular, the medicament may reduce adverse side effects of chemotherapeutics in chemotherapy of malignant tumor to enhance efficacy of said therapy and improve prognostic survival of patients suffering from malignant tumor.
    Type: Application
    Filed: January 21, 2010
    Publication date: May 13, 2010
    Applicant: Juridical Foundation the Chemo-Sero-Therapeutic Research Institute
    Inventors: Kenji OKAJIMA, Fujio Matsuo, Hiroyuki Sutoh, Yoichi Ogata, Tomohiro Nakagaki
  • Medicament for Improving Prognostic Survival in Therapy of Malignant Tumor
    Publication number: 20080182791
    Abstract: A medicament for improving prognostic survival in therapy of malignant tumor is provided that may improve prognostic survival in DIC patients where the basal disease is malignant tumor, especially malignant tumor in hematopoietic organs. The medicament according to the invention comprises as a main active ingredient Activated Protein C, which is obtained from plasma or prepared by using the genetic recombination technique, and efficiently prolongs life-span of DIC patients where the basal disease is malignant tumor, especially malignant tumor in hematopoietic organs. In particular, the medicament may reduce adverse side effects of chemotherapeutics in chemotherapy of malignant tumor to enhance efficacy of said therapy and improve prognostic survival of patients suffering from malignant tumor.
    Type: Application
    Filed: February 22, 2008
    Publication date: July 31, 2008
    Applicant: Juridical Foundation the Chemo-Sero-Therapeutic Research Institute
    Inventors: Kenji Okajima, Fujio Matsuo, Hiroyuki Sutoh, Yoichi Ogata, Tomohiro Nakagaki
  • Agent for improving life expectancy in therapy of malignant tumor
    Publication number: 20060094650
    Abstract: A medicament for improving prognostic survival in therapy of malignant tumor is provided that may improve prognostic survival in DIC patients where the basal disease is malignant tumor, especially malignant tumor in hematopoietic organs. The medicament according to the invention comprises as a main active ingredient Activated Protein C, which is obtained from plasma or prepared by using the genetic recombination technique, and efficiently prolongs life-span of DIC patients where the basal disease is malignant tumor, especially malignant tumor in hematopoietic organs. In particular, the medicament may reduce adverse side effects of chemotherapeutics in chemotherapy of malignant tumor to enhance efficacy of said therapy and improve prognostic survival of patients suffering from malignant tumor.
    Type: Application
    Filed: December 26, 2003
    Publication date: May 4, 2006
    Applicant: Juridical Foundation the Chemo-Sero- Therapeutic Research Institute
    Inventors: Kenji Okajima, Fujio Matsuo, Hiroyuki Sutoh, Yoichi Ogata, Tomohiro Nakagaki